Zhang, Xiamei
1Oncology Disease Area, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
3 papers on CoChat
Most cited papers
- Verified
IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism
Grassian, A. R., Parker, S. J., Davidson, S. M., Divakaruni, A. S., Green, C. R., Zhang, X., Slocum, K. L., Pu, M., Lin, F., Vickers, C., et al. (2014) · Cancer Research
Cancer, Hypoxia, and MetabolismCancer, Lipids, and Metabolism
Cited by 280
- Verified
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling
Liu, C., Lu, H., Wang, H., Loo, A., Zhang, X., Yang, G., Kowal, C., Delach, S., Wang, Y., Goldoni, S., et al. (2021) · Clinical Cancer Research
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 167
- Verified
A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection
Suzuki, E., Kim, S., Cheung, H.-K., Corbley, M. J., Zhang, X., Sun, L., Shan, F., Singh, J., Lee, W.-C., Albelda, S. M., et al. (2007) · Cancer Research
TGF-β signaling in diseasesOccupational and environmental lung diseases
Cited by 113
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free